Bovine Cough: Treatment Approach
For bovine cough associated with bovine respiratory disease (BRD), administer florfenicol 20 mg/kg IM with a second dose 48 hours later, or tulathromycin as a single-dose alternative, targeting the bacterial pathogens Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni. 1, 2
Initial Clinical Assessment
Recognize that cough is the single most reliable clinical sign associated with pneumonia in cattle across all production types and ages, though its sensitivity as a standalone diagnostic criterion remains limited (37.4% sensitivity, 85.7% specificity). 3
Key clinical parameters to evaluate:
- Spontaneous or induced cough - the only clinical sign consistently associated with ultrasound-confirmed lung consolidation in dairy, beef, and veal calves 3
- Rectal temperature ≥39.4°C - significant in beef and veal calves, though less reliable in dairy calves 3
- Respiratory rate and pattern - acute respiratory distress with rapid, shallow, open-mouth breathing suggests severe disease or atypical interstitial pneumonia 4, 5
- Duration of clinical signs - animals may progress from clinically normal to severe respiratory distress within 12 hours in acute cases 4
Antimicrobial Treatment Protocol
First-Line Therapy: Florfenicol
For treatment of BRD, administer florfenicol (Norfenicol) 20 mg/kg (3 mL/100 lbs) by intramuscular injection, with a mandatory second dose 48 hours later. 1
- Alternative single-dose regimen: 40 mg/kg (6 mL/100 lbs) subcutaneously in the neck only, not exceeding 10 mL per injection site 1
- Critical injection site: Use only the neck for subcutaneous administration to minimize tissue reaction and trim loss at slaughter 1
- Expected response time: Clinical improvement should be evident within 24 hours; if no positive response within 72 hours, re-evaluate the diagnosis 1
Alternative Therapy: Tulathromycin
Tulathromycin (DRAXXIN) is indicated for treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in calves, offering single-dose convenience. 2
Differential Diagnosis Considerations
Atypical Interstitial Pneumonia (AIP)
If cattle present with acute respiratory distress, open-mouth breathing, and rapid progression despite being clinically normal 12 hours earlier, consider atypical interstitial pneumonia rather than infectious BRD. 4, 5
- Causative agents: L-tryptophan metabolites (3-methylindole) from lush pasture, perilla mint, moldy sweet potatoes 4, 5
- Pathophysiology: Metabolic activation of xenobiotic compounds causing Clara cell and type I alveolar epithelial cell death 5
- Treatment limitation: Primarily symptomatic and often ineffective; prevention through pasture management is key 4
- Seasonal pattern: Predominantly occurs in late summer or fall when cattle are moved to lush pasture 4
Infectious BRD
BRD results from multifactorial interaction of stressors, animal susceptibility, and respiratory pathogens that are ubiquitous in cattle populations. 6
- Primary bacterial pathogens: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni 1, 2
- Secondary pathogens: Mycoplasma bovis, viral agents 2, 6
- Predisposing factors: Stress from transport, weaning, commingling, environmental changes 6
Treatment Algorithm
- Identify cough (spontaneous or induced) as primary clinical indicator 3
- Assess fever (≥39.4°C) and respiratory distress severity 3, 4
- If infectious BRD suspected: Initiate florfenicol 20 mg/kg IM immediately, repeat in 48 hours 1
- If acute respiratory distress with rapid progression: Consider AIP; remove from toxic pasture, provide supportive care 4, 5
- Evaluate response at 24-72 hours: If no improvement, re-evaluate diagnosis and consider alternative pathogens or non-infectious causes 1
Critical Pitfalls to Avoid
- Do not delay antimicrobial treatment - early recognition and treatment are essential for effectiveness in BRD 6
- Do not exceed 10 mL per injection site when using subcutaneous florfenicol 1
- Do not inject subcutaneous florfenicol outside the neck - other sites cause more severe tissue reaction 1
- Do not rely on cough alone for individual animal treatment decisions - sensitivity is too low (37.4%) for antimicrobial stewardship 3
- Do not assume all respiratory disease is infectious - AIP requires different management focused on toxin removal rather than antimicrobials 4, 5
Prevention Strategies
Address management procedures to minimize stressors rather than relying solely on vaccination, as BRD pathogens are ubiquitous and stressors are necessary to initiate disease. 6